HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Metabolism of irinotecan and its active metabolite SN-38 by intestinal microflora in rats.

Abstract
One of the dose-limiting toxicities of irinotecan (CPT-11) is delayed-onset diarrhea, which is the greatest barrier to treatment with CPT-11-containing regimens. CPT-11 is converted to its active metabolite, SN-38, which is conjugated by hepatic uridine diphosphate glucuronosyl transferase to SN-38 glucuronide (SN-38G). SN-38G, once excreted in the intestinal lumen via bile, is extensively deconjugated by bacterial beta-glucuronidase with the regeneration of SN-38 in the intestinal lumen, which may cause diarrhea. However, the metabolism of CPT-11 and its metabolites by intestinal microflora are yet to be reported. This study was carried out to investigate the microbial transformation of CPT-11 and SN-38 using an anaerobic mixed culture of rat cecal microorganisms. No reaction in the mixed cultures was observed when CPT-11 or SN-38 lactone was added to the culture medium. When CPT-11 was added to the culture broth, a significant amount of water-soluble CPT-11 was detected in the spent culture medium. In contrast, only a slight amount of SN-38 was found in the supernatant when SN-38 lactone was added to the broth. A significant quantity of SN-38 was found in the sediment. In conclusion, these results strongly suggest that SN-38 produced from SN-38G by the action of bacterial beta-glucuronidase is rapidly adsorbed by the intestinal bacterial cell walls in the sediment because of the hydrophobic and lipophilic nature of SN-38, and a small amount of SN-38 remains in the intestinal luminal fluid. Thus, we need to reconsider the role of SN-38 in the intestinal lumen in CPT-11-induced late-onset diarrhea.
AuthorsMichiko Yamamoto, Akinobu Kurita, Takashi Asahara, Akira Takakura, Ken Katono, Maiko Iwasaki, Shinichiro Ryuge, Mayuko Wada, Sayaka Onoda, Tomoko Yanaihara, Masanori Yokoba, Hisashi Mitsufuji, Yasuto Nishii, Tomoya Fukui, Noriyuki Masuda
JournalOncology reports (Oncol Rep) Vol. 20 Issue 4 Pg. 727-30 (Oct 2008) ISSN: 1021-335X [Print] Greece
PMID18813810 (Publication Type: Journal Article)
Chemical References
  • Antineoplastic Agents, Phytogenic
  • Irinotecan
  • Camptothecin
Topics
  • Animals
  • Antineoplastic Agents, Phytogenic (metabolism)
  • Bacteria (metabolism)
  • Camptothecin (adverse effects, analogs & derivatives, metabolism)
  • Diarrhea (chemically induced)
  • Intestines (microbiology)
  • Irinotecan
  • Male
  • Rats
  • Rats, Wistar

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: